It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Staphylococcus aureus bacteremia (SAB) is a heterogeneous disease with changing epidemiology due to changing demographics and evolving clinical management. SAB is associated with high mortality, but the current fraction of infection-related mortality is less well quantified.
Methods
In a multicenter prospective cohort study of consecutive patients with SAB, we determined clinical features of SAB and determined 90-day mortality and risk factors of all-cause and infection-related mortality. Infection-related mortality was based on an adjudication committee evaluation.
Results
Four hundred ninety patients with SAB were included, with community-acquired (n = 166), health care–associated (n = 163), and hospital-acquired SAB (n = 161). Endocarditis (n = 90, 18.3%), peripheral intravenous catheter infection (n = 80, 16.3%), and septic arthritis (n = 58, 11.8%) were the most frequent diagnoses, but proportions differed for community, health care, and hospital acquisition. One hundred ninety-two patients (39%) had permanent implanted prosthetic material (eg, prosthetic joint, heart valve, pacemaker). Day 90 all-cause mortality was 33% (n = 161), with 60% adjudicated as infection-related, and 90% of infection-related deaths occurring in the first 30 days post-SAB. Infection-related deaths after 30 days were rare and mainly related to endocarditis. Determinants associated with day 90 infection-related mortality were age (odds ratio [OR], 1.09; 95% CI, 1.06–1.11), Charlson comorbidity index (OR, 1.13; 95% CI, 1.01–1.26), septic shock (OR, 9.78; 95% CI, 4.56–20.95), endocarditis (OR, 3.4; 95% CI, 1.75–6.61), and persistent SAB at 48 hours (OR, 2.36; 95% CI, 1.27–4.37).
Conclusions
Mortality due to S. aureus infection remains high and mainly occurs in the first 30 days, which could guide end points in future studies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University , Utrecht , the Netherlands
2 Division of Infectious Diseases, Department of Internal Medicine, Amsterdam UMC, University of Amsterdam , Amsterdam , the Netherlands
3 Department of Internal Medicine, Spaarne Gasthuis , Haarlem , the Netherlands
4 Department of Internal Medicine, Noordwest Ziekenhuisgroep , Alkmaar , the Netherlands
5 Department of Internal Medicine, OLVG , Amsterdam , the Netherlands
6 Regional Public Health Laboratory Kennemerland , Haarlem , the Netherlands
7 Department of Medical Microbiology, Noordwest Ziekenhuisgroep , Alkmaar , the Netherlands
8 Department of Medical Microbiology, OLVG , Amsterdam , the Netherlands